Stay up-to-date on current diabetes themes, proven therapeutic options, and knowledge resources and tools for you and your patients, and find detailed information on Novo Nordisk diabetes products.
We have products for rare bleeding disorders, growth hormone-related disorders, and women’s health.
We are world leaders in diabetes care with a growing business in other treatment areas like haemophilia. We are more than 39,000 employees in 75 countries. Join us!
The investment is estimated to create close to 700 new production and engineering jobs in Clayton where Novo Nordisk already employs more than 700 people.
As the world's leading diabetes care company, we believe that to do what is good for the patient, we must do what is good for the world.
Learn more about Novo Nordisk in the U.S.
Novo Nordisk's passion for its people begins with meeting the needs of its diverse team, and empowering employees.
NBA Hall of Famer Dominique Wilkins knows it takes a team to help manage type 2 diabetes.
NCQA has reviewed and certified Novo Nordisk Inc.’s Diabetes Education Program Design capability.
Learn about our protein-based medicines for:
Hemophilia and other medical conditions
Novo Nordisk plans $2 billion U.S. dollar investment in new production facilities in Clayton, N.C. and Måløv, Denmark
Aug 26, 2015
Job Alert Be the first to know